174 related articles for article (PubMed ID: 19478238)
1. Benzene-induced hematopoietic neoplasms including myeloid leukemia in Trp53-deficient C57BL/6 and C3H/He mice.
Kawasaki Y; Hirabayashi Y; Kaneko T; Kanno J; Kodama Y; Matsushima Y; Ogawa Y; Saitoh M; Sekita K; Uchida O; Umemura T; Yoon BI; Inoue T
Toxicol Sci; 2009 Aug; 110(2):293-306. PubMed ID: 19478238
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic neoplastic diseases develop in C3H/He and C57BL/6 mice after benzene exposure: strain differences in bone marrow tissue responses observed using microarrays.
Inoue T; Hirabayashi Y
Chem Biol Interact; 2010 Mar; 184(1-2):240-5. PubMed ID: 20018183
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of nonthreshold leukemogenic response to methyl nitrosourea in p53-deficient C3H/He mice.
Hirabayashi Y; Yoshida K; Aizawa S; Kodama Y; Kanno J; Kurokawa Y; Yoshimura I; Inoue T
Toxicol Appl Pharmacol; 2003 Aug; 190(3):251-61. PubMed ID: 12902196
[TBL] [Abstract][Full Text] [Related]
4. p53 (TRP53) deficiency-mediated antiapoptosis escape after 5 Gy X irradiation still induces stem cell leukemia in C3H/He mice: comparison between whole-body assay and bone marrow transplantation (BMT) assay.
Yoshida K; Hirabayashi Y; Wada S; Watanabe F; Watanabe K; Aizawa S; Inoue T
Radiat Res; 2007 Jun; 167(6):703-10. PubMed ID: 17523849
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic analysis of radiation-induced leukemia in Trp53-deficient C3H/He mice.
Ban N; Yoshida K; Aizawa S; Wada S; Kai M
Radiat Res; 2002 Jul; 158(1):69-77. PubMed ID: 12071805
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice.
Hirouchi T; Takabatake T; Yoshida K; Nitta Y; Nakamura M; Tanaka S; Ichinohe K; Oghiso Y; Tanaka K
Exp Hematol; 2008 Jul; 36(7):871-85. PubMed ID: 18375040
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice.
Hulla JE; French JE; Dunnick JK
Carcinogenesis; 2001 Jan; 22(1):89-98. PubMed ID: 11159746
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.
French JE; Lacks GD; Trempus C; Dunnick JK; Foley J; Mahler J; Tice RR; Tennant RW
Carcinogenesis; 2001 Jan; 22(1):99-106. PubMed ID: 11159747
[TBL] [Abstract][Full Text] [Related]
9. A lower dose threshold for the in vivo protective adaptive response to radiation. Tumorigenesis in chronically exposed normal and Trp53 heterozygous C57BL/6 mice.
Mitchel RE; Burchart P; Wyatt H
Radiat Res; 2008 Dec; 170(6):765-75. PubMed ID: 19138040
[TBL] [Abstract][Full Text] [Related]
10. Stem-cell leukemia: p53 deficiency mediated suppression of leukemic differentiation in C3H/He myeloid leukemia.
Yoshida K; Aizawa S; Watanabe K; Hirabayashi Y; Inoue T
Leuk Res; 2002 Dec; 26(12):1085-92. PubMed ID: 12443880
[TBL] [Abstract][Full Text] [Related]
11. Nephrotoxicity and hepatotoxicity induced by inhaled bromodichloromethane in wild-type and p53-heterozygous mice.
Torti VR; Cobb AJ; Everitt JI; Marshall MW; Boorman GA; Butterworth BE
Toxicol Sci; 2001 Dec; 64(2):269-80. PubMed ID: 11719710
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous p53-deficient mice are not susceptible to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) carcinogenicity.
Park CB; Kim DJ; Uehara N; Takasuka N; Hiroyasu BT; Tsuda H
Cancer Lett; 1999 May; 139(2):177-82. PubMed ID: 10395176
[TBL] [Abstract][Full Text] [Related]
13. Benzene, the exposome and future investigations of leukemia etiology.
Smith MT; Zhang L; McHale CM; Skibola CF; Rappaport SM
Chem Biol Interact; 2011 Jun; 192(1-2):155-9. PubMed ID: 21333640
[TBL] [Abstract][Full Text] [Related]
14. Exposure of hematopoietic stem cells to benzene or 1,4-benzoquinone induces gender-specific gene expression.
Faiola B; Fuller ES; Wong VA; Pluta L; Abernethy DJ; Rose J; Recio L
Stem Cells; 2004; 22(5):750-8. PubMed ID: 15342939
[TBL] [Abstract][Full Text] [Related]
15. Cancer and non-cancer risks in normal and cancer-prone Trp53 heterozygous mice exposed to high-dose radiation.
Carlisle SM; Burchart PA; Mitchel RE
Radiat Res; 2010 Jan; 173(1):40-8. PubMed ID: 20041758
[TBL] [Abstract][Full Text] [Related]
16. A retrospective cohort study of cause-specific mortality and incidence of hematopoietic malignancies in Chinese benzene-exposed workers.
Linet MS; Yin SN; Gilbert ES; Dores GM; Hayes RB; Vermeulen R; Tian HY; Lan Q; Portengen L; Ji BT; Li GL; Rothman N;
Int J Cancer; 2015 Nov; 137(9):2184-97. PubMed ID: 25944549
[TBL] [Abstract][Full Text] [Related]
17. Physiologically based toxicokinetic modeling of secondary acute myelolytic leukemia.
Mukhopadhyay MK; Nath D
Environ Toxicol Pharmacol; 2014 Jan; 37(1):378-89. PubMed ID: 24440606
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia.
Folkerts H; Hilgendorf S; Wierenga ATJ; Jaques J; Mulder AB; Coffer PJ; Schuringa JJ; Vellenga E
Cell Death Dis; 2017 Jul; 8(7):e2927. PubMed ID: 28703806
[TBL] [Abstract][Full Text] [Related]
19. Fractionated, low-dose-rate ionizing radiation exposure and chronic ulcerative dermatitis in normal and Trp53 heterozygous C57BL/6 mice.
Mitchel RE; Burchart P; Wyatt H
Radiat Res; 2007 Dec; 168(6):716-24. PubMed ID: 18088189
[TBL] [Abstract][Full Text] [Related]
20. Prenatal radiation-induced limb defects mediated by Trp53-dependent apoptosis in mice.
Wang B; Ohyama H; Haginoya K; Odaka T; Yamada T; Hayata I
Radiat Res; 2000 Dec; 154(6):673-9. PubMed ID: 11096424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
